Ingalls & Snyder LLC decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 140,322 shares of the company’s stock after selling 4,032 shares during the period. Ingalls & Snyder LLC’s holdings in Colgate-Palmolive were worth $10,587,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Jacobi Capital Management LLC boosted its holdings in shares of Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares during the last quarter. Krilogy Financial LLC boosted its holdings in shares of Colgate-Palmolive by 23.0% during the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the last quarter. Captrust Financial Advisors acquired a new stake in shares of Colgate-Palmolive during the second quarter worth $122,000. AlphaMark Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the last quarter. Finally, Bruderman Asset Management LLC acquired a new stake in shares of Colgate-Palmolive during the second quarter worth $126,000. 72.96% of the stock is owned by institutional investors.
Several equities research analysts have recently issued reports on the company. SunTrust Banks upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their price objective for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Jefferies Group restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a report on Friday. Societe Generale cut Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective on the stock. in a report on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Friday, January 5th. Finally, Citigroup decreased their price objective on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a report on Thursday, November 2nd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and six have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $77.17.
Colgate-Palmolive (NYSE:CL) opened at $73.56 on Monday. Colgate-Palmolive has a fifty-two week low of $63.43 and a fifty-two week high of $77.91. The firm has a market capitalization of $64,593.42, a price-to-earnings ratio of 25.63, a P/E/G ratio of 3.06 and a beta of 0.80. The company has a debt-to-equity ratio of 24.42, a current ratio of 0.47 and a quick ratio of 0.34.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter last year, the firm earned $0.75 earnings per share. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. equities analysts forecast that Colgate-Palmolive will post 3.16 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s payout ratio is currently 70.18%.
ILLEGAL ACTIVITY WARNING: This news story was published by BBNS and is the sole property of of BBNS. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://baseballnewssource.com/markets/ingalls-snyder-llc-sells-4032-shares-of-colgate-palmolive-cl/1873752.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.